JJC8-089
JJC8-089 is a dopamine reuptake inhibitor (DRI) that was derived from modafinil and is related to JJC8-016, JJC8-088, and JJC8-091.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
JJC8-089 is a dopamine reuptake inhibitor (DRI) that was derived from modafinil and is related to JJC8-016, JJC8-088, and JJC8-091. Its affinity (K i ) for the dopamine transporter (DAT) is 37.8 nM, for the norepinephrine transporter (NET) is 11,820 nM (313-fold lower than for the DAT), for the serotonin transporter (SERT) is 6,800 nM (180-fold lower than for the DAT), and for the sigma σ 1 receptor is 2.24 nM (17-fold higher than for the DAT).
It also has significant affinity for several dopamine receptors. JJC8-089 has substantially higher affinity for the DAT than modafinil. The drug shows pro-motivational effects in animals.
It was first described in the scientific literature by 2016.
See also
List of modafinil analogues and derivatives
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368721223 under CC BY-SA 4.0; modifications have been made.